Posts in tag
direct acting antivirals
Hepatitis C: implications for practice
Treatment for chronic hepatitis C has been available through community pharmacies since 2016, but the predicted uptake of treatment has been lower than anticipated. Pharmacists have a key role to …
PBS listing for first pan-genotypic antiviral hep C treatment
Hepatitis Australia has welcomed today’s announcement that a new hepatitis C drug will be listed on the PBS Epclusa, the first pan-genotypic antiviral, will be PBS listed from 1 August, …
PBS listing of hep C drugs leads to 10x uptake
More Australians were treated for hep C since DAAs were added to the PBS than in the past decade, according to new report Since direct-acting antiviral (DAA) hepatitis C treatments …
Safety warning: DAAs linked to hepatitis B risk
The hep C medicines have been associated with reactivation of the hep B virus, which can lead to liver failure and even death A TGA review has found evidence of …